| Literature DB >> 30285112 |
Manuel Gonzales1, Margaret C Baker2, Ana Celestino3, Danerys Santa Morillo3, Amy Chambliss4, Sarah Adams5, Margaret Gyapong6, Dominique Kyelem7.
Abstract
BACKGROUND: While progress has been made in the elimination of lymphatic filariasis, challenges that call for innovative approaches remain. Program challenges are increasingly observed in 'hard-to-reach' populations: urban dwellers, migrant populations, those living in insecurity, children who are out of school and areas where infrastructure is weak and education levels are low. 'Business-as-usual' approaches are unlikely to work. Tailored solutions are needed if elimination goals are to be reached. This article focuses on mass drug administrations (MDAs) in urban settings.Entities:
Keywords: lymphatic filariasis; mass drug administration; neglected tropical diseases; urban
Mesh:
Year: 2019 PMID: 30285112 PMCID: PMC6398592 DOI: 10.1093/inthealth/ihy059
Source DB: PubMed Journal: Int Health ISSN: 1876-3405 Impact factor: 2.473
Study participants
| Type of participant | Instrument used | Total number of participants |
|---|---|---|
| Community recipients of MDA | 3 FGDs | 30 |
| Community drug distributors and supervisors | 3 FGDs | 33 |
| Community leaders | 1 FGD | 10 |
| LF program staff | 1 FGD | 8 |
| LF program directors | 2 interviews | 2 |
| NGO program managers | 2 interviews | 2 |
Framework for understanding the factors influencing treatment coverage obtained by LF MDAs
Knowledge of disease—although in-depth knowledge of the disease has not been found to be an important predictor of compliance, some knowledge of LF, especially of mosquitoes as transmitters, and that MDAs are to prevent LF are positive predictors of MDA participation. Perception of risk. Perception of benefits of taking part in MDAs, including deworming benefits. Awareness of the program and knowledge of the elimination strategy. Experiences during previous MDAs. Dislike of normal minor side effects. Rumors about negative side effects of drugs, including that they cause sterility. General dislike for modern medicine. Lack of trust in drugs (poor quality, too many, too big). Peer pressure to participate. Trust in persons delivering the MDA—affected by whether they are known, from the same area, from the same caste and their status in the community (e.g. respected health worker). |
Community organizations utilized to help mobilize the MDA. |
Quality of supervision. Monitoring ingestion of medication through directly observed MDA. Availability of human resources, often increased by using community volunteers as drug distributors. Knowledge and skills of the drug distributors. Quality training. Motivation of drug distributors and health staff. Logistics—drug and materials supply, timing of MDAs, availability of funding. Inability to monitor treatment coverage (poor numerators and/or denominators). |
Figure 1.Map showing the location of the study site—La Ciénaga, Santo Domingo, Dominican Republic. Image captured from Google Maps in 2011.
Illustrative study participant quotes
| Recipient’s willingness to comply—knowledge, attitudes and beliefs |
|---|
‘When I saw that they showed me the pictures of a man who had his.. his parts, the testicles of that size, I said: “wow”, because I had not wanted to take them (the tablets),…when they showed me that I said: “shit”…that was the means by which I was convinced to take them’. ‘…one would talk to them and explain well what the disease was, then at a given moment one would show them the photos and they would tell you: look at that, it’s because of this disease that we have to take the tablets, because if you do not this can happen, when they saw the testicles they would say: ayy! No, give me the tablets because I am going to take them, I am going to take them’. |
‘…I had the experience of some young people, because some young people were chosen to medicate,…that were youth from the barrios who were not community leaders, and there were people who would not allow themselves to be treated because there was no trust, but once a community leader went, they would see a community leader directing the process, they would say: “no problem”. With the simple act of seeing a community leader, there was no need to give much explanation’. |
‘[leading to success was] |
Figure 2.Illustration of the most utilized words that appear in the transcripts.
Summary of strategies and activities used to obtain good coverage in this urban MDA
| Strategy | Activities |
|---|---|
| Strong awareness campaign and high program visibility | Multiple communication channels |
| Clear messaging, e.g. ‘disease that affects the hanging parts’ | |
| House-to-house health education during MDA | |
| Laminated photo sheets | |
| About 400 persons in streets during weekend MDA, wearing distinctive program T-shirts and caps | |
| Peer-to-peer communication as MDA was ‘talk of the town’ | |
| Manage side effects proactively | All drug distributors and supervisors take medicine during training giving experience and building confidence |
| Local doctors trained and health centers open during the weekend to address side effects | |
| Free drugs for managing side effects | |
| Immediate response by supervisors to all persons with side effects | |
| Build trust | Recruitment in the community of drug distributors who treat those close to their own homes where they are known |
| Drug distributors given official identity cards and uniforms (T-shirts and caps) | |
| Investment in training drug distributors to be professional | |
| Supervision by more senior, and better known, community members | |
| Leverage social capital | Used community structure and existing leadership |
| Community designed and led MDA, including the selection of drug distributors and first-level supervisors | |
| Use of an NGO as an intermediary that is already known to the community | |
| Easy access | Free treatment |
| Combined use of house-to-house and fixed posts | |
| Weekend based when people not at work | |
| Follow-up weekday and evenings | |
| Build strong capacity in drug distributors with quality supervision | Quality training—maximum of 30 persons, national program trainers, interactive pedagogical methods and repetition of learning |
| Ratio of one first-level community supervisor to four drug distributors | |
| Use local maps to clearly assign treatment and supervision areas | |
| Directly observed treatment is closely monitored | |
| Adapted monitoring | Pre-MDA census led by a person with training in how to do a census |
| Recording of external population treated on separate tally forms | |
| Post-MDA coverage survey | |
| Strategic use of available resources | Use of a national team to lead urban MDA |